Supplemental Evidence and Data Request on Systematic Review of Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries, 17428-17430 [2017-07157]
Download as PDF
<![CDATA[
17428
Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices
Method of Collection
To achieve the goals of this project,
the following data collections will be
implemented:
AHRQ Research Reporting System
(ARRS)—Grantees and vendors use the
ARRS system to report project progress
and important preliminary findings for
grants and contracts funded by the
Agency. Grantees and vendors submit
progress reports on a monthly or
quarterly basis which are reviewed by
AHRQ personnel. All users access the
ARRS system through a secure online
interface which requires a user I.D. and
password entered through the ARRS
login screen. When status reports are
due AHRQ notifies principal
investigators and vendors via email.
The ARRS is an automated, userfriendly resource that is utilized by
AHRQ staff for preparing, distributing,
and reviewing reporting requests to
grantees and vendors for the purpose of
information sharing. AHRQ personnel
are able to systematically search the
information collected and stored in the
ARRS database. Personnel will also use
the information to address internal and/
or external requests for information
regarding grant progress, preliminary
findings, and other requests, such as
Freedom of Information Act requests
and producing responses related to
federally mandated programs and
regulations.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondents. It will take grantees and
vendors an estimated 10 minutes to
enter the necessary data into the ARRS
System and reporting will occur four
times annually. The total annualized
burden hours are estimated to be 333
hours.
Exhibit 2 shows the estimated
annualized cost burden for the
respondents. The total estimated cost
burden for respondents is $12,454.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses per
respondent
Hours per
response
Total
burden hours
Data entry into ARRS ......................................................................................
500
4
10/60
333
Total ..........................................................................................................
500
N/A
N/A
333
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Form name
Total burden
hours
Average
hourly wage
rate *
Total cost
burden
Data entry into ARRS ......................................................................................
500
333
$37.40
$12,454
Total ..........................................................................................................
500
333
N/A
12,454
* Based upon the average wages for Healthcare Practitioner and Technical Occupations (29–0000), ‘‘National Compensation Survey: Occupational Wages in the United States, May 2015,’’ U.S. Department of Labor, Bureau of Labor Statistics, https://www.bls.gov/oes/current/oes_
nat.htm#29-0000.
srobinson on DSK5SPTVN1PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
VerDate Sep<11>2014
20:18 Apr 10, 2017
Jkt 241001
comments will become a matter of
public record.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–07156 Filed 4–10–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Systematic Review of
Breastfeeding Programs and Policies,
Breastfeeding Uptake, and Maternal
Health Outcomes in Developed
Countries
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
SUMMARY:
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
scientific information submissions from
the public. Scientific information is
being solicited to inform our review of
Systematic Review of Breastfeeding
Programs and Policies, Breastfeeding
Uptake, and Maternal Health Outcomes
in Developed Countries, which is
currently being conducted by the
AHRQ’s Evidence-based Practice
CentersProgram. Access to published
and unpublished pertinent scientific
information will improve the quality of
this review.
DATES: Submission Deadline on or
before May 11, 2017.
ADDRESSES:
Email submissions: SEADS@epcsrc.org.
Print submissions: Mailing Address:
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, P.O. Box 69539, Portland,
OR 97239.
Shipping Address (FedEx, UPS, etc.):
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
E:\FR\FM\11APN1.SGM
11APN1
srobinson on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices
Coordinator, 3710 SW U.S. Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Ryan McKenna, Telephone: 503–220–
8262 ext. 51723 or Email: SEADS@epcsrc.org.
SUPPLEMENTARY INFORMATION: The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Systematic Review of
Breastfeeding Programs and Policies,
Breastfeeding Uptake, and Maternal
Health Outcomes in Developed
Countries. AHRQ is conducting this
systematic review pursuant to Section
902(a) of the Public Health Service Act,
42 U.S.C. 299a(a).
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Systematic Review of
Breastfeeding Programs and Policies,
Breastfeeding Uptake, and Maternal
Health Outcomes in Developed
Countries, including those that describe
adverse events. The entire research
protocol, including the key questions, is
also available online at: https://
effectivehealthcare.ahrq.gov/search-forguides-reviews-and-reports/
?pageaction=displayproduct
&productID=2455
This is to notify the public that the
EPC Program would find the following
information on Systematic Review of
Breastfeeding Programs and Policies,
Breastfeeding Uptake, and Maternal
Health Outcomes in Developed
Countries helpful:
D A list of completed studies that
your organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov,
please provide a summary, including
the following elements: Study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
VerDate Sep<11>2014
20:18 Apr 10, 2017
Jkt 241001
D A list of ongoing studies that your
organization has sponsored for this
indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including a study number, the
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, and primary and secondary
outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this indication and an
index outlining the relevant information
in each submitted file.
Your contribution will be very
beneficial to the EPC Program. The
contents of all submissions will be made
available to the public upon request.
Materials submitted must be publicly
available or able to be made public.
Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on indications not included
in the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program Web site and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://
www.effectivehealthcare.ahrq.gov/
index.cfm/join-the-email-list1/.
The systematic review will answer the
following questions. This information is
provided as background. AHRQ is not
requesting that the public provide
answers to these questions.
The Key Questions
KQ 1a. What is the effectiveness and
harms of programs and policies on
initiation, duration, and exclusivity of
breastfeeding?
KQ 1b. To what extent do the
effectiveness and harms of programs
and policies on initiation, duration, and
exclusivity of breastfeeding differ for
subpopulations of women defined by
sociodemographic factors (e.g., age, race,
ethnicity, socioeconomic status)?
KQ 1c. To what extent do
intervention-related characteristics (e.g.,
type of breast pump provided—manual
or electric; delivery personnel)
influence the initiation, duration, and
exclusivity of breast feeding?
KQ 2a. What are the comparative
benefits and harms for maternal health
outcomes among women who breastfeed
for different intensities and durations?
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
17429
KQ 2b. To what extent do benefits
and harms for maternal health outcomes
differ for subpopulations of women
defined by age, race, ethnicity, and
comorbidity?
Population(s)
KQs 1, 2: Childbearing women and
adolescents; we will also search for
evidence on subgroups of women
defined by age, race, ethnicity,
comorbidity, and socioeconomic status
(including insurance status and payer
type).
Interventions/Exposure
KQ 1: Community, workplace, and
health care system-based interventions
aimed at promoting and supporting
breastfeeding, including the following:
Health plan benefits, state and federal
policies or programs (e.g., WIC
programs), hospital implementation of
the BFHI, workplace or school-based
programs, and others. For studies
assessing the effectiveness of BFHI, we
will include studies evaluating full and
partial implementation (at least 3 steps)
of the 10 steps.
KQ 2: Exposure to breastfeeding.
Comparators
KQ 1: No intervention (or usual
practice); comparisons of two
interventions that differ in content or
intensity.
KQ 2: No breastfeeding; shorter
duration of breastfeeding (e.g.,
breastfeeding for 1 month vs. 12
months) and/or less intensive
breastfeeding (e.g., exclusive
breastfeeding vs. mixed feeding or
formula feeding).
Outcomes
KQ 1: Rates of breastfeeding initiation;
duration and exclusivity of
breastfeeding, adverse effects of
interventions (e.g., guilt about not
breastfeeding, workplace
discrimination, and other reported
harms).
KQ 2: Postpartum depression, breast
cancer, ovarian cancer, osteoporosis,
cardiovascular outcomes (e.g., stroke,
myocardial infarction), postpartum
weight change, type 2 diabetes,
hypertension.
Timing
KQs 1, 2: We will have no minimum
study duration or length of follow up.
Settings
KQs 1, 2: Studies conducted in a
developed country [‘‘very high’’ (KQs 1,
2) and ‘‘high’’ (KQ 1) human
development index per the United
Nations Development Programme 40.
E:\FR\FM\11APN1.SGM
11APN1
17430
Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices
Study Design
KQ 1: Randomized and nonrandomized controlled clinical trials;
prospective cohort studies with
concurrent control groups; systematic
reviews; for studies assessing policy or
system-level interventions, we will also
include pre-post studies with repeated
outcome measures before and after the
intervention.
KQ 2: Randomized and nonrandomized controlled clinical trials;
cohort studies; case-control studies;
systematic reviews.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017–07157 Filed 4–10–17; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Supplemental Evidence and Data
Request on Lower Limb Prosthesis
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for supplemental
evidence and data submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
the public. Scientific information is
being solicited to inform our review of
Lower Limb Prosthesis, which is
currently being conducted by the
AHRQ’s Evidence-based Practice
Centers Program. Access to published
and unpublished pertinent scientific
information will improve the quality of
this review.
DATES: Submission Deadline on or
before May 11, 2017.
ADDRESSES:
Email submissions: SEADS@epcsrc.org.
Print submissions:
Mailing Address: Portland VA
Research Foundation, Scientific
Resource Center, ATTN: Scientific
Information Packet Coordinator, P.O.
Box 69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.):
Portland VA Research Foundation,
Scientific Resource Center, ATTN:
Scientific Information Packet
Coordinator, 3710 SW U.S. Veterans
Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT:
Ryan McKenna, Telephone: 503–220–
8262 ext. 51723 or Email: SEADS@epcsrc.org.
srobinson on DSK5SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
20:18 Apr 10, 2017
Jkt 241001
The
Agency for Healthcare Research and
Quality has commissioned the
Evidence-based Practice Centers (EPC)
Program to complete a review of the
evidence for Lower Limb Prosthesis
(LLP). AHRQ is conducting this
systematic review pursuant to Section
902(a) of the Public Health Service Act,
42 U.S.C. 299a(a).
The EPC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by requesting information
from the public (e.g., details of studies
conducted). We are looking for studies
that report on Lower Limb Prosthesis,
including those that describe adverse
events. The entire research protocol,
including the key questions, is also
available online at: https://
effectivehealthcare.ahrq.gov/search-forguides-reviews-and-reports/
?pageaction=displayproduct&product
ID=2451
This is to notify the public that the
EPC Program would find the following
information on Lower Limb Prosthesis
helpful:
D A list of completed studies that
your organization has sponsored for this
indication. In the list, please indicate
whether results are available on
ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
D For completed studies that do not
have results on ClinicalTrials.gov,
please provide a summary, including
the following elements: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to follow-up/withdrawn/
analyzed, effectiveness/efficacy, and
safety results.
D A list of ongoing studies that your
organization has sponsored for this
indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the
trial is not registered, the protocol for
the study including a study number, the
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, and primary and secondary
outcomes.
D Description of whether the above
studies constitute ALL Phase II and
above clinical trials sponsored by your
organization for this indication and an
index outlining the relevant information
in each submitted file.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Your contribution will be very
beneficial to the EPC Program. The
contents of all submissions will be made
available to the public upon request.
Materials submitted must be publicly
available or able to be made public.
Materials that are considered
confidential; marketing materials; study
types not included in the review; or
information on indications not included
in the review cannot be used by the EPC
Program. This is a voluntary request for
information, and all costs for complying
with this request must be borne by the
submitter.
The draft of this review will be posted
on AHRQ’s EPC Program Web site and
available for public comment for a
period of 4 weeks. If you would like to
be notified when the draft is posted,
please sign up for the email list at:
https://www.effectivehealthcare.
ahrq.gov/index.cfm/join-the-email-list1/
.
The systematic review will answer the
following questions. This information is
provided as background. AHRQ is not
requesting that the public provide
answers to these questions.
The Key Questions
Key Question 1
What assessment techniques used to
measure functional ability of adults
with major lower limb amputation have
been evaluated in the published
literature?
I. What are the measurement
properties of these techniques,
including: Reliability, validity,
responsiveness, minimal detectable
change, and minimal important
difference?
II. What are the characteristics of the
participants in studies evaluating
measurement properties of assessment
techniques?
Key Question 2
What prediction tools used to predict
functional outcomes in adults with
major lower limb amputation have been
evaluated in the published literature?
I. What are their characteristics,
including technical quality (reliability,
validity, responsiveness), minimal
detectable change, and minimal
important difference?
II. What are the characteristics of the
participants in these studies?
Key Question 3
What functional outcome
measurement tools used to assess adults
who use a lower limb prosthesis (LLP)
have been evaluated in the published
literature?
I. What are their characteristics,
including technical quality (reliability,
E:\FR\FM\11APN1.SGM
11APN1
]]>Agencies
[Federal Register Volume 82, Number 68 (Tuesday, April 11, 2017)]
[Notices]
[Pages 17428-17430]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07157]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Supplemental Evidence and Data Request on Systematic Review of
Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal
Health Outcomes in Developed Countries
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Request for supplemental evidence and data submissions.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is
seeking scientific information submissions from the public. Scientific
information is being solicited to inform our review of Systematic
Review of Breastfeeding Programs and Policies, Breastfeeding Uptake,
and Maternal Health Outcomes in Developed Countries, which is currently
being conducted by the AHRQ's Evidence-based Practice CentersProgram.
Access to published and unpublished pertinent scientific information
will improve the quality of this review.
DATES: Submission Deadline on or before May 11, 2017.
ADDRESSES:
Email submissions: src.org">SEADS@epc-src.org.
Print submissions: Mailing Address: Portland VA Research
Foundation, Scientific Resource Center, ATTN: Scientific Information
Packet Coordinator, P.O. Box 69539, Portland, OR 97239.
Shipping Address (FedEx, UPS, etc.): Portland VA Research
Foundation, Scientific Resource Center, ATTN: Scientific Information
Packet
[[Page 17429]]
Coordinator, 3710 SW U.S. Veterans Hospital Road, Mail Code: R&D 71,
Portland, OR 97239.
FOR FURTHER INFORMATION CONTACT: Ryan McKenna, Telephone: 503-220-8262
ext. 51723 or Email: src.org">SEADS@epc-src.org.
SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and
Quality has commissioned the Evidence-based Practice Centers (EPC)
Program to complete a review of the evidence for Systematic Review of
Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal
Health Outcomes in Developed Countries. AHRQ is conducting this
systematic review pursuant to Section 902(a) of the Public Health
Service Act, 42 U.S.C. 299a(a).
The EPC Program is dedicated to identifying as many studies as
possible that are relevant to the questions for each of its reviews. In
order to do so, we are supplementing the usual manual and electronic
database searches of the literature by requesting information from the
public (e.g., details of studies conducted). We are looking for studies
that report on Systematic Review of Breastfeeding Programs and
Policies, Breastfeeding Uptake, and Maternal Health Outcomes in
Developed Countries, including those that describe adverse events. The
entire research protocol, including the key questions, is also
available online at: https://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=2455
This is to notify the public that the EPC Program would find the
following information on Systematic Review of Breastfeeding Programs
and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in
Developed Countries helpful:
[ssquf] A list of completed studies that your organization has
sponsored for this indication. In the list, please indicate whether
results are available on ClinicalTrials.gov along with the
ClinicalTrials.gov trial number.
[ssquf] For completed studies that do not have results on
ClinicalTrials.gov, please provide a summary, including the following
elements: Study number, study period, design, methodology, indication
and diagnosis, proper use instructions, inclusion and exclusion
criteria, primary and secondary outcomes, baseline characteristics,
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
[ssquf] A list of ongoing studies that your organization has
sponsored for this indication. In the list, please provide the
ClinicalTrials.gov trial number or, if the trial is not registered, the
protocol for the study including a study number, the study period,
design, methodology, indication and diagnosis, proper use instructions,
inclusion and exclusion criteria, and primary and secondary outcomes.
[ssquf] Description of whether the above studies constitute ALL
Phase II and above clinical trials sponsored by your organization for
this indication and an index outlining the relevant information in each
submitted file.
Your contribution will be very beneficial to the EPC Program. The
contents of all submissions will be made available to the public upon
request. Materials submitted must be publicly available or able to be
made public. Materials that are considered confidential; marketing
materials; study types not included in the review; or information on
indications not included in the review cannot be used by the EPC
Program. This is a voluntary request for information, and all costs for
complying with this request must be borne by the submitter.
The draft of this review will be posted on AHRQ's EPC Program Web
site and available for public comment for a period of 4 weeks. If you
would like to be notified when the draft is posted, please sign up for
the email list at: https://www.effectivehealthcare.ahrq.gov/index.cfm/join-the-email-list1/.
The systematic review will answer the following questions. This
information is provided as background. AHRQ is not requesting that the
public provide answers to these questions.
The Key Questions
KQ 1a. What is the effectiveness and harms of programs and policies
on initiation, duration, and exclusivity of breastfeeding?
KQ 1b. To what extent do the effectiveness and harms of programs
and policies on initiation, duration, and exclusivity of breastfeeding
differ for subpopulations of women defined by sociodemographic factors
(e.g., age, race, ethnicity, socioeconomic status)?
KQ 1c. To what extent do intervention-related characteristics
(e.g., type of breast pump provided--manual or electric; delivery
personnel) influence the initiation, duration, and exclusivity of
breast feeding?
KQ 2a. What are the comparative benefits and harms for maternal
health outcomes among women who breastfeed for different intensities
and durations?
KQ 2b. To what extent do benefits and harms for maternal health
outcomes differ for subpopulations of women defined by age, race,
ethnicity, and comorbidity?
Population(s)
KQs 1, 2: Childbearing women and adolescents; we will also search
for evidence on subgroups of women defined by age, race, ethnicity,
comorbidity, and socioeconomic status (including insurance status and
payer type).
Interventions/Exposure
KQ 1: Community, workplace, and health care system-based
interventions aimed at promoting and supporting breastfeeding,
including the following: Health plan benefits, state and federal
policies or programs (e.g., WIC programs), hospital implementation of
the BFHI, workplace or school-based programs, and others. For studies
assessing the effectiveness of BFHI, we will include studies evaluating
full and partial implementation (at least 3 steps) of the 10 steps.
KQ 2: Exposure to breastfeeding.
Comparators
KQ 1: No intervention (or usual practice); comparisons of two
interventions that differ in content or intensity.
KQ 2: No breastfeeding; shorter duration of breastfeeding (e.g.,
breastfeeding for 1 month vs. 12 months) and/or less intensive
breastfeeding (e.g., exclusive breastfeeding vs. mixed feeding or
formula feeding).
Outcomes
KQ 1: Rates of breastfeeding initiation; duration and exclusivity
of breastfeeding, adverse effects of interventions (e.g., guilt about
not breastfeeding, workplace discrimination, and other reported harms).
KQ 2: Postpartum depression, breast cancer, ovarian cancer,
osteoporosis, cardiovascular outcomes (e.g., stroke, myocardial
infarction), postpartum weight change, type 2 diabetes, hypertension.
Timing
KQs 1, 2: We will have no minimum study duration or length of
follow up.
Settings
KQs 1, 2: Studies conducted in a developed country [``very high''
(KQs 1, 2) and ``high'' (KQ 1) human development index per the United
Nations Development Programme 40.
[[Page 17430]]
Study Design
KQ 1: Randomized and non-randomized controlled clinical trials;
prospective cohort studies with concurrent control groups; systematic
reviews; for studies assessing policy or system-level interventions, we
will also include pre-post studies with repeated outcome measures
before and after the intervention.
KQ 2: Randomized and non-randomized controlled clinical trials;
cohort studies; case-control studies; systematic reviews.
Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-07157 Filed 4-10-17; 8:45 am]
BILLING CODE 4160-90-P
